跳至主要内容
临床试验/NCT01959984
NCT01959984Unknown不适用

Study on the Comparison Between"Standard Noodles" and Traditional Carbohydrates in the Diagnosis of Diabetes Mellitus.

Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2013年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
240
试验地点
1
主要终点
The c-peptide level.

研究概览

简要总结

The object of this study is to compare "100g Standard Noodles " with traditional carbohydrates including 75g glucose solution in 300ml water and 100g steamed bread in the diagnosis of diabetes mellitus.

In this study, we will compare the different effects of "100g Standard Noodles Tolerance Test"and "75g Oral Glucose Tolerance Test"on plasma glucose, insulin, c- peptide level and the relevant hormones level including glucagon-like peptide-1( GLP-1) and glucagon. Besides, in part of the subjects, the difference between "100g Steamed Bread Tolerance Test", "100g Standard Noodles Tolerance Test" and "75g Oral Glucose Tolerance Test" will be further evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
16 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion Criteria:
  • For healthy subjects:
  • Between 16-70 years old.
  • No weight fluctuation greater than 5% within 3 months.
  • Understand and voluntarily sign an informed consent document prior to any study related assessments/procedures .
  • For subjects with impaired glucose regulation(IGR):
  • Between 16-70 years old.
  • Impaired fasting glucose(IFG):6.1mM(109mg/ml)≤fasting plasma glucose(FPG)<7.0mM(126mg/ml),or impaired glucose tolerance(IGT):7.8mM(140mg/ml)≤2h plasma glucose(2hPG)<11.1mM(200mg/dl),or both.
  • No weight fluctuation greater than 5% within3 months.
  • Keep stable antidiabetic therapy for at least 2 months.
  • Understand and voluntarily sign an informed consent document prior to any study related assessments/procedures .
  • For subjects with type 2 diabetes mellitus(T2DM):
  • Between 16-70 years old.
  • T2DM:diabetic symptoms plus random blood glucose(RBG)≥11.1mM,or FPG ≥7.0mM(126mg/dl),or 2hPG ≥11.1mM(200mg/dl).
  • No weight fluctuation greater than 5% within 3 months.
  • Keep stable antidiabetic therapy at least for 2 months.
  • Understand and voluntarily sign an informed consent document prior to any study related assessments/procedures.
  • For subjects with type 1 diabetes mellitus(T1DM):
  • Between 16-70 years old.
  • T1DM:diabetic symptoms plus RBG≥11.1mM,or FPG ≥7.0mM(126mg/dl),or 2hPG ≥11.1mM(200mg/dl).
  • Present at least one positive antibody of β cell including ICA,IAA,GADA,IA-2A and IA-2βA.
  • No weight fluctuation greater than 5% within 3 months.
  • Keep stable antidiabetic therapy for at least 2 months.
  • Understand and voluntarily sign an informed consent document prior to any study related assessments/procedures.

排除标准

  • For healthy subjects:
  • Be diagnosed with diabetes or IGR in late 3 months.
  • With any significant medical condition,laboratory abnormality,or psychiatric disorders that will prevent the subject from participating in the study.
  • Any medical or surgical conditions possibly affecting the experiment result.
  • Participated in a clinical study involving administration of medication within 90 days.
  • Donated blood or plasma or had any other significant blood loss within 2 months.
  • Any clinically significant allergic diseases.
  • Recently drug or alcohol abuse(>35unit/week,1unit=8 g alcohol@1 standard drink@250ml beer@140ml wine@25ml strong alcohol drink like whiskey.)
  • Smokers or users of other tobacco products in the 3 months prior to screening.
  • For IGR and DM:
  • History of pancreatic diseases such as pancreatic cancer or pancreatitis.
  • Suffered from acute complications such as diabetic ketoacidosis and hyperosmolar coma within 3 months.
  • With any significant medical condition,laboratory abnormality,or psychiatric disorders that will prevent the subject from participating in the study.
  • Malignant tumor.
  • Being allergic to experiment arms.
  • Recently drug or alcohol abuse(>35unit/week,1unit=8 g alcohol@1 standard drink@250ml beer@140ml wine@25ml strong alcohol drink like whiskey.)

研究组 & 干预措施

100g Standard Noodles

Experimental

100g Standard Noodles

干预措施: 100g Standard Noodles (Other)

75g Oral Glucose

Experimental

75g Oral Glucose

干预措施: 75g Oral Glucose (Other)

结局指标

主要结局

The c-peptide level.

时间窗: 12 months

The primary outcome measures the c-peptide level at 0min,30min,60min,120min,180min during "75g Oral Glucose Tolerance Test" and "100g Standard Noodles Tolerance Test" .

The plasma glucose level.

时间窗: 12 months

The primary outcome measures the plasma glucose level at 0min,30min,60min,120min,180min during "75g Oral Glucose Tolerance Test" and "100g Standard Noodles Tolerance Test" .

The insulin level.

时间窗: 12 months

The primary outcome measures the insulin level at 0min,30min,60min,120min,180min during "75g Oral Glucose Tolerance Test" and "100g Standard Noodles Tolerance Test" .

次要结局

  • The Glucagon level.(12 months)
  • The other relevant incretin hormones levels.(12 months)
  • The plasma glucose, insulin, c-peptide and relevant incretin hormones level during "75g Oral Glucose Tolerance Test", "100g Standard Noodles Tolerance Test" and "100g Steamed Bread Tolerance Test".(12 months)
  • The GLP-1 level.(12months)

研究者

发起方
Shanghai Jiao Tong University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Guang Ning

the vice-president of Shanghai Jiao Tong University Affiliated Ruijin Hospital

Shanghai Jiao Tong University School of Medicine

研究点 (1)

Loading locations...

相似试验